Ser298 of MITF, a mutation site in Waardenburg syndrome type 2, is a phosphorylation site with functional significance

Human Molecular Genetics

Volumn 9, Issue 1, 2000, Pages 125-132

  Takeda, Kazuhisa ^a,b   Takemoto, Clifford ^c   Kobayashi, Ichiro ^b,f   Watanabe, Atsushi ^b,g   Nobukuni, Yoshitaka ^d,h   Fisher, David E ^c   Tachibana, Masayoshi ^b,e  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^e SAITAMA CANCER CENTER   (Japan)

^f HOKKAIDO UNIVERSITY   (Japan)

^g NIPPON MEDICAL SCHOOL   (Japan)

^h KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3; PHOSPHOSERINE; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENE MUTATION; HUMAN; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PHOSPHORYLATION; TRANSACTIVATION; WAARDENBURG SYNDROME;

ANIMALIA;

EID: 0034110297     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/9.1.125     Document Type: Article

References (36)

1. Tachibana, M., Perez-Jurado, L.A., Nakayama, A., Hodgkinson, C.A., Li, X, Schneider, M., Miki, T., Fex, J., Francke, U. and Arnheiter, A. (1994) Cloning of MITF, the human homolog of the mouse microphthalmia gene and assignment to chromosome 3p14.1-p12.3. Hum. Mol. Genet., 3, 553-557.
2. Hemesath, T.J., Steingrímsson, E.S., McGill, G., Hansen, M.J., Vaught, J., Hodgkinson, C.A., Arnheiter, H., Copeland, N.G., Jenkins, N.A. and Fisher, D. (1994) microphthalmia, a critical factor in melanocyte development, defines a discrete transcription factor family. Genes Dev., 8, 2770-2780.
3. Nobukuni, Y., Watanabe, A., Takeda, K., Skarka, H. and Tachibana, M. (1996) Analyses of loss-of-function mutations of the MITF gene suggest that haploinsufficiency is a cause of Waardenburg syndrome type 2A. Am. J. Hum. Genet., 59, 76-83.
4. Bentley, N.J., Eisen, T. and Goding, C.R. (1994) Melanocyte-specific expression of the human tyrosinase promoter: activation by the microphthalmia gene product and role of the initiator. Mol. Cell. Biol., 14, 7996-8006.
5. Yasumoto, K., Mahalingam, H., Suzuki, H., Yoshizawa, M., Yokoyama, K. and Shibahara, S. (1995) Transcriptional activation of the melanocyte-specific genes by the human homolog of the mouse microphthalmia protein. J. Biochem., 118, 874-881.
6. Yasumoto, K., Yokoyama, K., Shibata, K., Tomita, Y. and Shibahara, S. (1995) Microphthalmia-associated transcription factor as a regulator for melanocyte-specific transcription of the human tyrosinase gene. Mol. Cell. Biol., 14, 8058-8070.
7. Tachibana, M., Takeda, K., Nobukuni, Y., Urabe, K., Long, J.E., Meyers, K.A., Aaronson, S.A. and Miki, T. (1996) Ectopic expression of MITF, a gene for Waardenburg syndrome type 2, converts fibroblasts to cells with melanocyte characteristics. Nature Genet., 14, 50-61.
8. Tassabehji, M., Newton, V.E. and Read, A.P. (1994) Waardenburg syndrome type 2 caused by mutations in the human microphthalmia (MITF) gene. Nature Genet., 8, 251-255.
9. Tassabehji, M., Newton, V.E., Liu, X.Z., Brady, A., Donnai, D., Krajewska-Walasek, M., Murday, V., Norman, A., Obersztyn, E., Rice, J.C. et al. (1995) The mutational spectrum in Waardenburg syndrome. Hum. Mol. Genet., 4, 2131-2137.
10. Amiel, J., Watkin, P.M., Tassabehji, M., Read, A.P. and Winter, R.M. (1998) Mutation of the MITF gene in albinism-deafness syndrome (Tietz syndrome). Clin. Dysmorphol., 7, 17-20.
11. Steingrímsson, E., Moore, K.J., Lamoreux, M.L., Ferré-D'Amaré, A.R., Burley, S.K., Zimring, D.C.S., Skow, L.C., Hodgkinson, C.A., Arnheiter, H., Copeland, N.G. and Jenkins, N.A. (1994) Molecular basis of mouse microphthalmia (mi) mutations helps explain their developmental and phenotypic consequences. Nature Genet., 8, 256-263.
12. He, X., Siant-Jeannet, J.-P., Woodgett, J.R. Varmus, H.E. and Dawid, I.B. (1995) Glycogen synthase kinase-3 and dorsoventral patterning in Xenopus embryos. Nature, 374, 617-622.
13. Courey, A.J. and Tjian, R. (1988) Analysis of Sp1 in vivo reveals multiple transcriptional domains, including a novel glutamine-rich activation motif. Cell, 55, 887-898.
14. Ferreri, K., Gill, G. and Montminy, M. (1994) The cAMP-regulated transcription factor CREB interacts with a component of the TFIID complex. Proc. Natl Acad. Sci. USA, 91, 1210-1213.
15. Matsuzaki, Y., Fujisawa, J. and Yoshida, M. (1995) Identification of transcriptional activation domain of TREB5, a CREB/ATF family protein that binds to HTLV-1 enhancer. J. Biochem., 117, 303-308.
16. Speipel, K., Georgiev, O. and Schaffner, W. (1992) Different activation domains stimulate transcription from remote ('enhancer') and proximal ('promoter') positions. EMBO J., 11, 4961-4968.
17. Sato, S., Roberts, K., Gambino, G., Cook, A., Kouzarides, T. and Goding, C.R. (1997) CBP/p300 as a cofactor for the Microphthalmia transcription factor. Oncogene, 14, 3083-3092.
18. Hunter, T. and Karin, M. (1992) The regulation of transcription by phosphorylation. Cell, 70, 375-387.
19. Li, L., Zhou, J., James, G., Heller-Harrison, R., Czech, M.P. and Olson, E.N. (1992) FGF inactivates myogenic helix-loop-helix proteins through phosphorylation of a conserved protein kinase C site in their DNA-binding domains. Cell, 71, 1181-1194.
20. Kapiloff, M.S., Farkash, Y., Wegner, M. and Rosenfeld, M.G. (1991) Variable effects of phosphorylation of Pit-1 dictated by the DNA response elements. Science, 253, 786-789.
21. Manak, J.R., de Bisshop, N., Kris, R.M. and Prywes, R. (1990) Casein kinase II enhances the DNA binding activity of serum response factor. Genes Dev., 4, 955-967.
22. Janknecht, R., Hipskind, R.A., Houthaeve, T., Nordheim, A. and Stunnenberg, H.G. (1992) Identification of multiple SRF N-terminal phosphorylalion sites affecting DNA binding properties. EMBO J., 11, 1945-1054.
23. Hemesath, T.J., Price, E.R., Takemoto, C., Badalian, T. and Fisher, D.E. (1998) MAP kinase links the transcription factor Microphthalmia to c-Kit signaling in melanocytes. Nature, 391, 298-301.
24. Pearson, R.B. and Kemp, B.E. (1991) Protein kinase phosphorylation site sequences and consensus specificity motifs: tabulation. Methods Enzymol., 200, 62-81.
25. Fiol, C.J., Wang, A., Roeske, R.W. and Roach, P.J. (1990) Ordered multisite protein phosphorylation. Analysis of glycogen synthase kinase 3 action using model peptide substrates. J. Biol. Chem., 265, 6061-6065.
26. Wang, Q.M., Park, I.K., Fiol, C.J., Roach, P.I. and Depaoli-Roach, A.A. (1994) Isoform differences in substrate recognition by glycogen synthase kinase 3 alpha and 3 beta in the phosphorylation of phosphatase inhibitor 2. Biochemistry, 33, 143-147.
27. Boyle, W.J., Smeal, T., Defize, L.H., Angel, P., Woodgett, J.R., Karin, M. and Hunter, T. (1991) Activation of protein kinase C decreases phosphorylation of c-Jun at sites that negatively regulate its DNA-binding activity. Cell. 8, 573-584.
28. Hunter, T., Angel, P., Boyle, W.J., Chiu, R., Freed, E., Gould, K.L., Isacke, C.M., Karin, M., Lindberg, R.A. and van der Geer, P. (1988) Targets for signal-transducing protein kinases. Cold Spring Harbor Symp. Quant. Biol., 53, 131-142.
29. Dorsky, R.I., Moon, R.T. and Raible, D.W. (1998) Control of neural crest cell fate by the Wnt signaling pathway. Nature, 396, 370-373.
30. Aronzon, K.L., Takayama, H., Ponzetto, M.F., Merlino, G. and Pavan, W. (1999) Hepatocyte growth factor/scatter factor-MET signaling in neural crest-derived melanocyte development. Pigment Cell Res., 12, 13-21.
31. Papkoff, J. and Aikawa, M. (1998) WNT-1 and HGF regulate GSK3β activity and β-catenin signaling in mammary epithelial cells. Biochem. Biophys. Res. Commun., 247, 851-858.
32. Jones, D.H. and Howard, B.H. (1990) A rapid method for the site-specific mutagenesis and directional subcloning by using the polymerase chain reaction to generate recombinant circles. Biotechniques, 8, 178-183.
33. Shibata, K., Muraosa, Y., Tomita, Y., Tagami, H. and Shibahara, S. (1992) Identification of cis-acting element that enhances the pigment cell-specific expression of the human tyrosinase gene. J. Biol. Chem., 267, 20584-20588.
34. Keegan, L., Gill, G. and Ptashne, M. (1986) Separation of DNA binding from the transcription-activating function of a eukaryotic regulatory protein. Science, 231, 699-704.
35. Fields, S. and Jang, S.K. (1989) Presence of a potent transcription activation sequence in the p53 protein. Science, 249, 1046-1049.
36. Boyle, W., van der Geer, P. and Hunter, T. (1991) Phosphopeptide mapping and phosphoamino acid analysis by two-dimensional separation on thin-layer cellulose plates. Methods Enzymol., 210, 110-149.